Controls and Procedures.
−Removed: An evaluation was carried out by Embecta’s management, with the participation of Embecta’s Chief Executive Officer and Chief Financial Officer, of the effectiveness of the design and operation of Embecta’s disclosure controls and procedures (as defined in Rule 13a-15(e)
−Removed: under the Securities Exchange Act of 1934) as of December 31, 2021.
+Added: An evaluation was carried out by embecta’s management, with the participation of embecta’s Chief Executive Officer and Chief Financial Officer, of the effectiveness of the design and operation of embecta’s disclosure controls and procedures (as defined in Rule 13a-15(e) under the Securities Exchange Act of 1934) as of March 31, 2022.
Based upon that evaluation, the Chief Executive Officer and Chief Financial Officer concluded that the design and operation of these disclosure controls and procedures were, as of the end of the period covered by this report, effective and designed to ensure that material information relating to embecta and its consolidated subsidiaries would be made known to them by others within these entities.
−Removed: There were no changes in our internal control over financial reporting during the fiscal quarter ended December 31, 2021 identified in connection with the above-referenced evaluation that have materially affected, or are reasonably likely to materially affect, Embecta’s internal control over financial reporting.
+Added: There were no changes in our internal control over financial reporting during the fiscal quarter ended March 31, 2022 that have materially affected, or are reasonably likely to materially affect, embecta’s internal control over financial reporting.
+Added: Dollar amounts are in millions except per share amounts or as otherwise specified.
OTHER INFORMATION
−Removed: Legal Proceedings.
−Removed: Information with respect to this item may be found in Note 5, “Commitments and Contingencies” to the Condensed Combined Financial Statements in Item 1 of Part I.
−Removed: Risk Factors.
−Removed: There have been no material changes to Embecta’s risk factors from those described in “Risk Factors” in the Form 10.
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.